Consumer Health

Clinical trials play an important role in the development and lifecycle maintenance of consumer health products. They may be designed to confirm efficacy or safety or to evidence marketing claims for the product concerned. ClinChoice is a market leader in providing clinical development and related services to the Consumer Health sector. This means that when approaching the feasibility of a clinical trial in a consumer health product, ClinChoice is uniquely positioned to develop the optimal approach to country and site selection. Indeed, our experience extends to decentralized trials in Consumer Health, where the traditional model of the research site does not apply.

Feasibility Plus™

The majority of clients with whom we work have a clear picture of the use of their consumer health products and the desired location for their trials. That said, ClinChoice leverages our experience and local knowledge to support our clients with our guidance and advice to support their thinking. Feasibility Plus™ identifies the optimal locations and trial sites (where applicable) for Consumer Health projects.

The FeRMI System

FeRMI is ClinChoice’s revolutionary feasibility solution, which pioneered the use of a 100% e-solution with real-time data analysis. FeRMI boasts a robust data analysis and reporting module that enables simultaneous trend monitoring and shapes feasibility as data is collected. By collecting data electronically, information becomes instantly accessible on any device with a secure web connection. Through FeRMI, ClinChoice can rapidly collect and analyze feasibility datasets, including responses from hundreds of sites around the globe.

Our Site Selection Approach

Site selection is a critical element of a successful drug trial. We base site selection criteria on four guiding principles proven to guarantee complete enrollment according to predetermined timelines:

  • Predictability: The site should demonstrate a consistent track record of accurately forecasting patient enrollment, showcasing reliability in estimating the required numbers.
  • Enrollment: The site should exhibit a proven history of successfully enrolling the specified number of patients, demonstrating an ability to meet enrollment targets specific to drug trials.
  • Retention: A hallmark of professionalism and diligence at the site is essential to ensure optimal patient retention, emphasizing the importance of staff commitment and procedural adherence.
  • Data Quality: The site should possess extensive experience, qualified staff, and robust methodologies to guarantee the highest standards of data collection and management.

Proven Excellence

ClinChoice’s more than 28 years of experience in clinical trial conduct has enabled us to develop close links to a large number of high-quality, motivated investigational sites with high recruitment potential. We have a clear understanding of site capabilities on a global scale, ensuring site assignments possess the equipment and skills to perform non-standard clinical procedures.

Explore Related Study Start-Up Solutions